X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1072) 1072
Book Review (203) 203
Publication (100) 100
Book Chapter (8) 8
Dissertation (3) 3
Conference Proceeding (2) 2
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (802) 802
humans (687) 687
egfr (620) 620
female (383) 383
male (360) 360
oncology (299) 299
middle aged (279) 279
aged (261) 261
urology & nephrology (202) 202
glomerular filtration rate (194) 194
cancer (192) 192
adult (185) 185
epidermal growth factor (170) 170
chronic kidney disease (147) 147
animals (140) 140
analysis (131) 131
risk factors (126) 126
care and treatment (123) 123
glomerular-filtration-rate (122) 122
chemotherapy (119) 119
estimated glomerular filtration rate (119) 119
receptor, epidermal growth factor - metabolism (118) 118
growth-factor receptor (117) 117
aged, 80 and over (116) 116
gefitinib (116) 116
mutation (115) 115
receptor, epidermal growth factor - antagonists & inhibitors (109) 109
receptor, epidermal growth factor - genetics (105) 105
epidermal growth factor receptors (103) 103
medicine & public health (103) 103
research (102) 102
chronic kidney-disease (101) 101
antineoplastic agents - therapeutic use (97) 97
nephrology (96) 96
lung cancer (95) 95
lung neoplasms - drug therapy (91) 91
cell line, tumor (90) 90
mortality (90) 90
tumors (90) 90
disease progression (89) 89
kidney diseases (89) 89
pharmacology & pharmacy (89) 89
prognosis (87) 87
article (86) 86
treatment outcome (84) 84
therapy (82) 82
risk (81) 81
health aspects (80) 80
chronic kidney failure (79) 79
expression (78) 78
prevalence (78) 78
cell biology (77) 77
metastasis (75) 75
development and progression (73) 73
retrospective studies (73) 73
lung cancer, non-small cell (72) 72
erlotinib (70) 70
renal function (70) 70
acquired-resistance (69) 69
biochemistry & molecular biology (69) 69
carcinoma, non-small-cell lung - drug therapy (68) 68
medical research (67) 67
signal transduction (67) 67
cell lung-cancer (66) 66
kinases (66) 66
protein kinase inhibitors - therapeutic use (65) 65
serum creatinine (65) 65
survival (64) 64
epidermal growth factor receptor (63) 63
ckd (62) 62
diabetes (62) 62
disease (61) 61
genetic aspects (61) 61
apoptosis (60) 60
lung neoplasms - pathology (60) 60
tyrosine kinase inhibitors (60) 60
mice (59) 59
medicine, experimental (58) 58
open-label (58) 58
phosphorylation (58) 58
progression (58) 58
tyrosine (58) 58
hypertension (57) 57
lung neoplasms - genetics (57) 57
albuminuria (56) 56
patients (56) 56
breast cancer (55) 55
proteins (55) 55
quinazolines - therapeutic use (55) 55
renal insufficiency, chronic - physiopathology (55) 55
activation (53) 53
creatinine (53) 53
follow-up studies (53) 53
adenocarcinoma (52) 52
association (52) 52
prospective studies (52) 52
studies (52) 52
cohort studies (51) 51
creatinine - blood (50) 50
egfr mutations (50) 50
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Kidney Diseases, ISSN 0272-6386, 09/2019, Volume 74, Issue 3, pp. 310 - 319
The relationship between hypertension, antihypertension medication use, and change in glomerular filtration rate (GFR) over time among individuals with... 
Hypertension | CKD risk | blood pressure | kidney function | race | disease projection | estimated glomerular filtration rate (eGFR) | racial differences | African Americans | chronic kidney disease (CKD) | trajectory | DISPARITIES | RACIAL-DIFFERENCES | RACE | INSUFFICIENCY | UROLOGY & NEPHROLOGY | OUTCOMES | BURDEN | STAGE RENAL-DISEASE | BLOOD-PRESSURE | PROGRESSION | APOL1 RISK | Index Medicus
Journal Article
Journal Article
American Journal of Kidney Diseases, ISSN 0272-6386, 2016, Volume 68, Issue 2, pp. 193 - 202
Journal Article
Journal of Infectious Diseases, ISSN 0022-1899, 08/2014, Volume 210, Issue 3, pp. 363 - 373
Journal Article
Journal of the American Society of Nephrology, ISSN 1046-6673, 08/2018, Volume 29, Issue 8, pp. 2200 - 2212
Background Epidemic levels of CKD of undetermined cause, termed Mesoamerican nephropathy in Central America, have been found in low- and middle-income... 
NICARAGUAN SUGARCANE WORKERS | CKDu | PREVALENCE | CKD of unknown etiology | SERUM CREATININE | GLOMERULAR-FILTRATION-RATE | CENTRAL-AMERICA | MeN | DISEASE | UROLOGY & NEPHROLOGY | eGFR decline | Endemic nephropathy | EL-SALVADOR | Clinical Epidemiology
Journal Article
American Journal of Kidney Diseases, ISSN 0272-6386, 2015, Volume 66, Issue 6, pp. 945 - 950
Journal Article
American Journal of Kidney Diseases, ISSN 0272-6386, 07/2019, Volume 74, Issue 1, pp. 47 - 55
Progression of chronic kidney disease (CKD) in sickle cell disease (SCD) and its risk factors remain poorly defined. We identified characteristics associated... 
sickle hemoglobin | thalassemia | proteinuria | estimated glomerular filtration rate (eGFR) | Sickle cell disease | chronic kidney disease (CKD) | eGFR decline | hyperfiltration | genotype | HYPERFILTRATION | ALBUMINURIA | MICROALBUMINURIA | HYDROXYUREA | RENAL-FUNCTION | ADULTS | UROLOGY & NEPHROLOGY | PREVALENCE | CHRONIC KIDNEY-DISEASE | ENALAPRIL | CHILDREN
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2018, Volume 13, Issue 4, pp. e0195523 - e0195523
Urinary type IV collagen (U-Co14) and albumin excretion is evaluated to monitor the development of diabetic kidney disease. However, U-Co14 excretion in the... 
GFR DECLINE | MARKER | MULTIDISCIPLINARY SCIENCES | RENAL-FUNCTION | PROTEINURIA | RISK | ALBUMIN | FORMULA | ASSOCIATION | CKD | Chronic kidney failure | Collagen | Physiological aspects | Development and progression | Research | Diagnosis | Glomerular filtration rate | Index Medicus
Journal Article
American Journal of Kidney Diseases, ISSN 0272-6386, 01/2019, Volume 73, Issue 1, pp. 82 - 89
The standard method to calculate time to the event of a specified percentage decline in estimated glomerular filtration rate (eGFR) uses 2 eGFR assessments, 1... 
Estimated glomerular filtration rate (eGFR) | kidney function | time-to-event outcome | percent eGFR decline | kidney disease progression | eGFR trajectory | longitudinal data | simulations | KIDNEY-DISEASE | UROLOGY & NEPHROLOGY | END-POINTS | DESIGN | CKD | CLINICAL-TRIALS
Journal Article